Introduction
Fungal sinusitis is classified as invasive or noninvasive and chronicor acute. 1 Acuteinvasivefungal rhinosinusitis occurs moreoften in im munocompromised patients, and symptoms develop rapidly over days to weeks. Chronic invasive fungal sinusitis occurs in patients with little or no evidence of irnmunocompromise, and it tend s to present more insidiously over weeks to months.' The prognosi s generally depends more on the host's immune status than on the specific causative organism.
Traditionally, invasiveAspelKillussinusitishas been treated with extensive surgical debr idement followed by long-term antifungal therapy, primarilywith int ravenousamphotericin B. We describe a case in which th e patient ' s fragile condition and refusal to undergo surgery necessitated a novel approach to th erapy. 
Case report
An 89-year-oldwoman with asthma presented to our hospital with a I-year histo ry of facial and tooth pain and a runny nose. Both her dentist and her primary care physician had treated her with multiple coursesoforal ant ibiotics without any discernible improvement. She event ually underwent computed tomography (CT), which detected marked sinusitis with opacification of the left ethmoid and frontal sinuses. After consultation with an otol aryngologist, she unde rwent sinus surgery. The left ethmoid and maxillary sinuses were drained, and an inferior meatus ant rostomy was performed. Exten sive necrosis and debris were noted intraoperatively. Subsequent findings on pathologic examination-hyphae associated with tissue necrosis, acute and chronic inflammation, and fungus balls-were consistent with a fungal infection . Six days after surgery, Aspergillus fitmigatus grew on culture. After the patient underwent inhaled amphotericin therapy for several weeks, she developed ocular immobility, increased tearing, and subsequent loss of vision in the left eye. At that point, the patient was referred to the emergency department at our hospital, where she underwent ophthalmologic and otolaryngologic evaluations. These examinations revealed left-sided blindness, ptosis, and a complete paralysis of the extraocul ar mu scles (figure 1). Soft-tissue swelling and eryrhema were noted on the left side of the face in the area surrounding the eye. A repeat CT (figure 2, A) and magnetic resonance imaging with gadolinium contrast both detected extensive invasive disease involving the nasoph arynx, infratemporal fossa, orbit, and cavernous sinus. No evidence of parenchymal disease was seen.
The infection rapidly worsened over the first 24 hours of hospitalization . The extensive involvement of critical structures and the patient's frailty and unwillingness to undergo a disfigurin g procedure precluded surgery, and we believed that her medical condition was too fragile to withstand IV amphotericin B therap y. Therefore, we consulted the literature for guidance. Although the literature supporting combination therapy with an echinocandin and a triazole for invasive aspergillosis was limited at the time, we decided that it was sufficient to justify a trial of counts, natural killer-cell activity, and imm unoglobulin levels." No uniform deficits were ident ified in that study.
Aspergillus species carry specific viru lence factors th at may explain th eir pro pensity to cause invasive disease, even in the ot herw ise normal host . Spor es produced by Aspergillus are tiny (3 to 5 prn), which allows them to penetrate deep into tissues. These spores may withstand extraordinary atmospheric con ditions owing to their coating layer of hydrophobic pro tein . The organisms efficiently bind laminin and fibrinogen, and they produce various pro teases, phospholipases, hemo lysin, and aflatoxin . ' Left unt reated, invasiveAsp elg-illussinusitiscarriesa nearly 100% mortality. However, treatment has been historically difficult and inconsiste ntly successful. Following debridement, an indu ction ph ase of treatment with high doses of IV amp hotericin B is generally initiated to achieve high dru g concentra tions. T his is followed by a consolidat ion or mainte nance ph ase, which sometimes includes the addition of ora l agents such as irraconazole.?Am photericin is a polyene macro lide that binds preferenti ally to ergostero l in the fungalcellmem brane; it also binds human cholesterol. It is difficult to admi nister and to tolera te because offrequent infus ion reactions, electrolyte wasting, and severe renal . 
Discussion
Chronic invasive fungal sinusitis is generally difficult to eradicate, it recurs frequen tly, and it carries a poor prog nosis. Patients may develop symptoms over prolonged periods; in such cases,theslow progression ofdisease hinders a diagnosis, aswas the casewith our patient. Frequently, in fact, a diagnosis is madeonlyafter the infection has invaded criticalstructures, which can take months to years to occur. Symptoms may not develop until the orbit or skull base becomes involved.' Erosion of fungal hyph ae int o th e orbit from the maxillary sinus may produce proptosis. Invasion of the cribriform plate can cause headaches, seizures, mental deterioration , or focal deficits. Extension th rough the sphenoid sinus may lead to cavernous sinus syndrome and cranial nerve deficits-again, as happ ened to our patient .' Patients can experience carastrophiccom plications, includ ing carotid artery rup ture, mycotic aneurysms, and cavernous sinus thrombosis. ' It is interesting that most pat ients with chro nic invasive fungal sinusitis are imm unologically intact, as was our patient. Washburn er al performed extensive testing on patients with invasivedisease; theseevaluations included measurements ofabsolut e neutroph il and mon ocyte counts, th e phagocyticand fung icidal activity ofperipheral blood rnon ocyt es, total lymphocyte combination caspofungin and vorico nazole. Our decision was based on studies showing that these two agents had a beneficial synergistic effect in an imals with experimental pu lmo nary aspergillosis.' Initially, the pat ient receiveda loadingdose ofcaspofun gin (70 mg IV) and two doses of voricon azole (6 mg/kg IV). T hereafter, she was administered IV caspofu ngin at 50 mg/day and IV vor iconazole at 4 mg/kg twice daily. T he vorico nazole was later administered as an oral form ulatio n (100 mg rwicedaily).T he patient remaine d on both medications for several months.T he concentra tion ofcaspofungin was event ually increased to minim ize fluid overload.
After only one do se of th is com binatio n, th e course of th e infection stabilized. T he patient experienced no further progression of her neurologic sym pto ms, and her facial edema and erythema abated . Serial.follow-up CTs confirmed th e considerable im provement ( figure 2, B) , which allowed us to perform a limi ted surgical debr idement. Subsequent cultures were negative for Aspergillus.
Wi th the exception of the blind ness in her left eye, th e patient experienced a complete resolution of symptoms. Drug toxicity was mi nimal. Combination therapy. In recent years, investigator s have studied the effectiveness of combining an echinocandin with a triazole.2.7·1 0-1 2 These two classes of drugs have different sites of action; echinocandins inhibit fungal cell wall form ation, and triazoles inhibit cell membrane synt hesis. T he sim ultaneous inhibition of the biosynthesis of key components of the fungal cell wall and membrane could theoretically result in a synergistic int eraction and increased killing. Petraitis et al tested th is theory by performing in vitro and animalstud ies ofexperimental invasive pulmonary aspergillosis in neutropenic rats. 2Th ese experim ent s demonstrated that combination treatm ent caused conc ent ration-dependent synergistic hyphal damage (p < 0.001) . In addition, ratswith invasive disease that received combination therapy experienced a significant reduction in fun gal burden in lun g tissue, greater survival, and less pulmonary injury, Then a lethal bolu s ofA fitlnigatus conidia was inoculated intravenously, wh ich dissemin ated disease to multiple organs, including th e liver, kidn ey, lun g, and brain. All 36 animals that were treated with eithe r caspofungin alone or voriconazole alone and all 12 control animals had at least one positive culture of organ tissue. The animals that received comb ination treatm ent had significantly fewer positive cultures of liver, lun g, kidne y, and brain tissues (p < 0.0025) .
M arr et al retrospectively studied the combination of caspofun gin and voricon azole as salvage the rapy in 47 pat ient s with proven or prob able invasive aspergillosis (includ ing extrapulmonary disease) who had failed to respond to amphotericin B.7Multivari ate analysesshowed th at the patients who received combination th erapy had a significantly greater 3-mont h survival than did tho se who had received voriconazole only (p = 0.011) . The results of this study, which was conducted at a large cancer center, are impressive, and they provide furthe r evidence that the comb ination may prove to be a safe and effectivealtern ative to traditio nal treatment modalities. Further data from larger randomized trials are necessary to confirm its efficacy as a primary and salvage the rapy.
Finally, our comprehensive literature review identified one othe r case report in which combination treatment with caspofun gin and voriconazole resulted in clinical and microbiologic cure of invasive sinus aspergillosis without the need for radical surgery.13Tsiodras er al treated a patient who had refused~o undergo surgery, including eye enucle-ENT-Ear, Nose & Throat Journal ' January 2008 ation, Instead th e patient received combination th erapy and repeated local debridernents, and he recovered com pletely. H owever, this case differs from ours in that th is patient had several predisposing facto rs for invasive fun gal sin usitis; he was diabetic, and he had received a liver transplant for hepatiti s C -related cirrhosis. Also, th is patient had developed fungal sin usitis while receiving system ic liposom al ampho tericin B, whereas our patient had received only inh aled am pho terici n.
While our case and the case repon ed by Tsiod ras et aJ1 3 are rare and were characterized by somewhat exten uating circumstan ces, each represents a clear case of successful treatment of th is invasive disease with 'relatively nontoxic med ications that spared bot h patient s radical: disfigur ing surgery.
Our experience suggests that combinat ion th erapy with caspo fungin and voriconazole may prove to be safe and effective in th e m anagem ent of invasive Aspergillus sin usitis, and we believe it sho uld be considere d a th erapeutic option in th e future.
T he different ial diagnosis ofa lon gstanding nasal foreign body sho uld include unilateral sinusitis, un ilateral nasal calcified polyp, osteoma , osteomyelitis, fun gal infection ," syphilis,' and benign and malign ant tu mo rs of th e nasal cavities. Axial and coronal CTs without cont rast enha ncement are useful for performing an accura te study of th e m ass an d its relation to adjacent structures.? but rigid nasal en doscopy is an ideal m eth od for establishi ng an instant diagnosis. ' In accordance with recommend ations published in th e literatu re, we remo ved th e foreign body from our patient via an endo nasal endosco pic appro ach with local anesthesia. After th e object was removed, the endoscop ic view of th e right nasal cavity confirme d th e hypoplasia of th e ipsilateral inferior turbinate.
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